174 related articles for article (PubMed ID: 3303480)
1. In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination.
Petersen E
Trans R Soc Trop Med Hyg; 1987; 81(2):238-41. PubMed ID: 3303480
[TBL] [Abstract][Full Text] [Related]
2. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole.
Khalil I; Rønn AM; Alifrangis M; Gabar HA; Satti GM; Bygbjerg IC
Am J Trop Med Hyg; 2003 May; 68(5):586-9. PubMed ID: 12812351
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of sulphamethoxazole/trimethoprim and sulfadoxine/pyrimethamine against Chlamydia trachomatis SA2f in McCoy cell culture.
Mumtaz G; Ridgway GL; Felmingham D
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):415-7. PubMed ID: 3137048
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana.
Marks F; Evans J; Meyer CG; Browne EN; Flessner C; von Kalckreuth V; Eggelte TA; Horstmann RD; May J
Antimicrob Agents Chemother; 2005 Mar; 49(3):1101-5. PubMed ID: 15728909
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Fansidar against Plasmodium falciparum in continuous culture.
Brockelman CR; Tan-Ariya P
Am J Trop Med Hyg; 1982 Sep; 31(5):913-8. PubMed ID: 6751112
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Plasmodium falciparum collected from pyrimethamine-sulfadoxine sensitive and resistant areas in Thailand.
Sabchareon A; Chongsuphajaisiddhi T; Attanath P; Kanjanapipatkul K; Doberstyn EB; Suebsaeng L
Bull World Health Organ; 1985; 63(3):597-602. PubMed ID: 3899396
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an in vitro test method for the assessment of sensitivity of Plasmodium falciparum to pyrimethamine and sulfadoxine.
Sabchareon A; Chongsuphajaisiddhi T; Attanath P; Meemanee B; Wernsdorfer W
Bull World Health Organ; 1987; 65(3):345-52. PubMed ID: 3311437
[TBL] [Abstract][Full Text] [Related]
8. Fansidar-resistant falciparum malaria in Papua New Guinea.
Darlow B; Vrbova H; Stace J; Heywood P; Aalpers M
Lancet; 1980 Dec; 2(8206):1243. PubMed ID: 6108409
[No Abstract] [Full Text] [Related]
9. [Chloroquine and fansidar resistance of Plasmodium falciparum now also in Ghana].
Kupferschmidt HG; Schröder K; Beltzner B
Angew Parasitol; 1988 Nov; 29(4):211-3. PubMed ID: 3072886
[TBL] [Abstract][Full Text] [Related]
10. Fansidar resistant falciparum malaria in Indonesia.
Rumans LW; Dennis DT; Atmosoedjono S
Lancet; 1979 Sep; 2(8142):580-1. PubMed ID: 89577
[No Abstract] [Full Text] [Related]
11. Falciparum malaria resistant to chloroquine, quinine and Fansidar in a non-immune patient infected in Ghana.
Nguyen C; Gregson D; Mouldey P; Keystone JS
Trans R Soc Trop Med Hyg; 1989; 83(4):485-6. PubMed ID: 2694485
[No Abstract] [Full Text] [Related]
12. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.
Schapira A; Bygbjerg IC; Jepsen S; Flachs H; Bentzon MW
Am J Trop Med Hyg; 1986 Mar; 35(2):239-45. PubMed ID: 3513641
[TBL] [Abstract][Full Text] [Related]
13. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy.
Wang P; Brobey RK; Horii T; Sims PF; Hyde JE
Mol Microbiol; 1999 Jun; 32(6):1254-62. PubMed ID: 10383765
[TBL] [Abstract][Full Text] [Related]
14. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro.
Chulay JD; Watkins WM; Sixsmith DG
Am J Trop Med Hyg; 1984 May; 33(3):325-30. PubMed ID: 6375404
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine-sulfadoxine (Fansidar). A study of alternate regimens in Eastern Thailand, 1980.
Reacher M; Campbell CC; Freeman J; Doberstyn EB; Brandling-Bennett AD
Lancet; 1981 Nov; 2(8255):1066-9. PubMed ID: 6118522
[TBL] [Abstract][Full Text] [Related]
16. The activity of pyrimethamine and sulphadoxine against Plasmodium falciparum determined by the in vitro microtechnique.
Eastham GM; Rieckmann KH
Trans R Soc Trop Med Hyg; 1983; 77(1):91-3. PubMed ID: 6344364
[TBL] [Abstract][Full Text] [Related]
17. Falciparum malaria resistant to Fansidar (sulphadoxine-pyrimethamine) occurring in three children of the same family.
Ponnampalam JT
Singapore Med J; 1982 Feb; 23(1):37-8. PubMed ID: 7051329
[No Abstract] [Full Text] [Related]
18. The first report of Plasmodium falciparum resistant to chloroquine plus sulphadoxine/pyrimethamine in Rwanda.
Giboda M; Vanista J; Dastych P
Trans R Soc Trop Med Hyg; 1988; 82(3):383. PubMed ID: 3068850
[No Abstract] [Full Text] [Related]
19. Fansidar-resistant falciparum malaria in Papua New Guinea.
Nurse GT
Lancet; 1981 Jan; 1(8210):36-7. PubMed ID: 6109064
[No Abstract] [Full Text] [Related]
20. Analysis of resistance to pyrimethamine/sulphadoxine of isolates of Plasmodium falciparum from Eastern Thailand.
Childs GE; Sabchareon A; Chongsuphajaisiddi T; Wimonwattrawatee T; Ratharatorn B; Webster HK
Trans R Soc Trop Med Hyg; 1986; 80(1):66-8. PubMed ID: 3523866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
